Header Logo

Connection

RACHELLE DOODY to Oligopeptides

Back to Details
This is a "connection" page, showing publications RACHELLE DOODY has written about Oligopeptides.
RACHELLE DOODY
Connection Strength
0.112
Oligopeptides
  1. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol. 2014 Jul; 13(7):676-85.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.